Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA24813F2073· VHA· 248-NETWORK CONTRACT OFFICE 8· 6505 · DRUGS AND BIOLOGICALS· FY2013· $361,674 net obligations· UEI H3WKVE9VBLY3· PA

Description

IGF::OT::IGF IMMOGLOBINE

First action · last action
2013-02-01 · 2013-04-03
Transactions
3
First transaction's obligation
$144,827
Base + all options value (sum of deltas)
$361,674
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5045B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$361,674$0Base award · 2013-02-01 · this action $144,827 · running total $144,827Modification P00002 · 2013-02-01 · this action $101,860 · running total $246,687Modification P00001 · 2013-04-03 · this action $114,987 · running total $361,674
  • Base2013-02-01+$144,827= $144,827
  • Mod P000022013-02-01+$101,860= $246,687
  • Mod P000012013-04-03+$114,987= $361,674
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-02-01+$144,827$144,827IGF::OT::IGF IMMOGLOBINE
Mod P00002· OTHER ADMINISTRATIVE ACTION2013-02-01+$101,860$246,687IGF::OT::IGF IMMOGLOBINE
Mod P00001· OTHER ADMINISTRATIVE ACTION2013-04-03+$114,987$361,674IGF::OT::IGF IMMOGLOBINE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24816P1268MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$16,913FY2016
VA24816P1163MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$10,115FY2016
VA24816F2241LANTHEUS MEDICAL IMAGING, INC.248-NETWORK CONTRACT OFFICE 8$4,288FY2016
VA24816F1125ASTELLAS PHARMA US, INC.248-NETWORK CONTRACT OFFICE 8$72,949FY2016
VA24016E0163MCKESSON CORPORATION248-NETWORK CONTRACT OFFICE 8$26,221,769FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24813F2073_3600_V797P5045B_3600 · retrieved 2026-09-26.